Biologics: Targets and Therapy
Volume 11, 2017 - Issue
Open access
72
Views
6
CrossRef citations to date
0
Altmetric
Review
Anti-angiogenic effects of biotechnological therapies in rheumatic diseases
Francesco Paolo Cantatore1 Rheumatology Clinic, Department of Medical and Surgical Sciences, University of Foggia Medical School, FoggiaCorrespondence[email protected]
, Nicola Maruotti1 Rheumatology Clinic, Department of Medical and Surgical Sciences, University of Foggia Medical School, Foggia
, Addolorata Corrado1 Rheumatology Clinic, Department of Medical and Surgical Sciences, University of Foggia Medical School, Foggia
& Domenico Ribatti2 Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School;3 National Cancer Institute “Giovanni Paolo II”, Bari, Italy
Pages 123-128
|
Published online: 14 Dec 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.